Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Depression × Mass Screening × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 6 Uterine Cervical Neoplasms 5 Breast Neoplasms 5 Neoplasms 4 Lung Neoplasms 3 Uterine Cervical Dysplasia 2 Prostatic Neoplasms 2 Warts 1 Urinary Bladder Neoplasms 1 Tinea 1 Skin Neoplasms 1 Papillomavirus Infections 1 Pancreatic Neoplasms 1 Nevus 1 Multiple Endocrine Neoplasia Type 1 1 Molluscum Contagiosum 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Cancer Screening 1 Liver Neoplasms 1 Keratosis, Actinic 1 Intestinal Neoplasms 1 Impetigo 1 Herpes Zoster 1 Hepatitis C 1 HIV Infections 1 Gastrointestinal Neoplasms 1 Financial Stress 1 Fibrosis 1 Erysipelas 1

Interventions

Therapeutics 21 Psychiatric Rehabilitation 16 Cognitive Behavioral Therapy 10 Psilocybin 8 Ketamine 8 Early Intervention, Educational 8 Yoga 6 Saline Solution 6 Methods 6 Counseling 6 Surveys and Questionnaires 5 Mindfulness-Based Cognitive Therapy 5 Esketamine 5 Behavior Therapy 5 Acupuncture Therapy 5 Psychosocial Intervention 4 Mindfulness 4 Interviews as Topic 4 Exercise Therapy 4 Educational Status 4 Control Groups 4 Psychotherapy 3 Palliative Care 3 Niacin 3 Methylphenidate 3 Melatonin 3 Meditation 3 Hypnosis 3 Ethanol 3 Escitalopram 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02273206 2020-03-12

PCM3

Clinical Directors Network

Phase NA Completed

802 enrolled 28 charts

Depression

Data powered by HemOnc (CC BY 4.0) Colophon ⚡